Top Markets
#1 Akedo Akedo +55.65%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +47.96%
#4 Velvet Velvet +38.39%
#5 Black Phoenix Black Phoenix +34.09%
#6 Cross Cross +24.27%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.20%
#8 QANplatform QANplatform +14.54%
#9 Perle Perle +13.89%
#10 Bitway Bitway +13.56%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Regenerative Medical Technology Group Inc. Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc.

RMTG
Rank in Stocks #38990
Regenerative Medical Technology Group Inc. operates in the regenerative... Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.
Share Price
$0.05315
Market Cap
$698.34K
Change (1 day)
-5.93%
Change (1 year)
-21.26%
Country
US
Trade Regenerative Medical Technology Group Inc. (RMTG)

Category

Healthcare
Revenue for Regenerative Medical Technology Group Inc. (RMTG)
Revenue in Aug 2026 TTM: 0
According to Regenerative Medical Technology Group Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Regenerative Medical Technology Group Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE